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Abstract P358 - Table 1. Proportion of subjects with limitation of each Activity of Daily Living (ADL)* 
<54 yrs 55-64 yrs 65-74 yrs 75-84 yrs 
1"4 = 9,966-10,110 1"4 = 4,876-4,938 1"4 = 10,697-10,934 1"4 = 7910-8217 
> 85 yrs 
N = 603-640 
Bathing 20% 22% 22% 29% 49% 
Dressing 21% 22% 20% 25% 39% 
Eating 14% 11% 11% 13% 24% 
Transfer from chair 34% 36% 36% 45% 58% 
Walking 43% 50% 50% 56% 69% 
Using toilet 14% 14% 13% 18% 30% 
*Differences ignificant for each ADL with p<0.001. 
Abstract P358 - Table 2. Multivariable-adjusted o ds ratio (95% Confidence interval) of each ADL limitation for various age categories 
Limitation in <54 yrs 55-64 yrs 65-74 yrs 75-84 yrs > 85 yrs 
Bathing 1 1.0 (0.9-1.1) 1.0 (0.9-1.1) 1.4 (1.2-1.6)* 4.4 (3.4-5.7)* 
Dressing 1 0.9 (0.8-1.0) 0.8 (0.7-0.9)* 1.0 (0.9-1.1 ) 2.8 (2.2-3.6)* 
Eating 1 0.8 (0.7-0.9)1 0.8 (0.7-0.95)1 1.1 (0.9-1.3) 2.8 (2.1-3.8)* 
Transfer from chair 1 0.9 (0.8-0.98)~: 0.9 (0.8-0.97)1 1.2 (1.1-1.3)* 2.6 (2.0-3.4)* 
Walking 1 1.0 (0.9-1.1) 0.9 (0.9-1.0) 1.1 (1.02-1.3)~: 2.5 (1.9-3.3)* 
Using toilet 1 0.9 (0.8-0.96)1 0.8 (0.7-0.9)* 1.1 (1.0-1.3) 2.7 (2.1-3.6)* 
*p <0.001; tP <0.01; ~:p<0.05 
survey included questions related to functional limitation as mea- 
sured by limitation of six Activities of Daily Living (ADLs; bathing, 
dressing, eating, transfer from chair, walking, and toileting), de- 
mographics, current smoking status, and self-report of physician 
diagnosed comorbidities. Cohort demographic and health care 
utilization data obtained from administrative databases supple- 
mented survey data. 
We used chi-square test to compare the proportion of subjects 
with ADL limitation in various age categories,and multivariable 
logistic regression analyses to obtain estimates of odds of limi- 
tation for each ADL (adjusted for demographic, smoking status, 
comorbidity and utilization variables) with age category as the 
main predictor and ADL limitation as the outcome. 
Results: Walking and transfer from chair were the most fre- 
quently limited ADLs and eating and using the toilet the least 
(Table 1). Veterans older than 75 and 85 years had significantly 
greater ADL limitation compared to younger subjects (Table 1). 
ADL limitation was similar for veterans 0-54, 55-64 and 65-74 
years of age, except for walking. 
In multivariable adjusted model, veterans 85 years and older had 
2.5-4.4 times higher odds of limitation of each ADL compared to 
those 54 years or younger (Table 2). 
Conclusions: Functional limitation increases significantly with 
age in veterans. Age is independently associated with functional 
limitation in veterans even after adjusting for socio-demographic, 
comorbidity and health care utilization differences. 
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Introduction: The UHS is the succession of events from the mo- 
ment in which the need of medical attention arises up to the mo- 
ment in which the medical attention begins. Some of the determi- 
nants of utilization of health services have been described: acces- 
sibility, pain threshold, confidence, culture, economic factor etc. 
Objective: To know the frequency, epidemiologic distribution of 
the UHS in Mexico in patients with rheumatic diseases (RD). 
Material and methods: We analyzed the information of adult sur- 
vey from The National Health Survey 2000. It is a population- 
based survey designed to collect information on the health of 
Mexican household population. The sample was drawn through 
a stratified proportional random sampling. We analyzed Epidemi- 
ological data from all patients who requested medical attention 
for a RD in the last 12 months. We describe demographic data 
of user due to RD, UHS for Mexican state and UHS for health 
institution. 
Results: We estimated that 25 millions of persons used some 
health services in Mexico, of these 206,366 pts. used them for a 
RD (1.3% of all users). 58% were women and 42% were men. 
The sixth decade (21.8%) was the more frequently age where 
people used services from our HS fora RD, except in third decade 
of age, in all decennial groups women demanded more HS. The 
national average of UHS was 3.13%, the three states of Mexico 
with more UHS were: Veracruz 12%, Hidalgo 9.5%, Estado de 
Mexico; However, we adjusted these percentages for state pop- 
ulation and the states with more UHS for a RD were: Estado de 
Mexico (2.72%), Campeche (2.64%) and Colima (2.52%). The 
states with minor UHS adjusted for state population were: San 
Luis Potosi 0.29%, Sinaloa 0.55%, Mexico, City 0.59%. The na- 
tional health institutions more demanded were: Private Practice 
42%, IMSS 29%, SS 17% and other 12%. Except en fifth decade 
of age, the Mexican population used more private practice than 
older population. 
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Fig. 1. Utilization of Health Services for National Health Institution and Age. 
Conclusions: The UHS in Mexico for RD is not low; women used 
more health services than men. Mexican Population demanded 
more private practice than government health institutions. There 
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are geographic differences in UHS in Mexican Population. It is 
necessary to investigate the determinant factors of the USS in 
Mexico. 
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Aim of Study: Osteoarthritis (OA) patients (pts) have been re- 
ported to use complementary and alternative medicine (CAM) 
therapies with higher frequency than the general population; how- 
ever, specific information has been scant and comparisons to 
other rheumatic disease patients have not been carried out. This 
pilot study was designed to gather information on CAM use in OA 
pts and to compare them to pts with rheumatoid arthritis (RA) and 
systemic lupus erythematosus (SLE). 
Methods: Questionnaires were mailed to pts seen in the outpa- 
tient practices of an academic medical center with a diagnosis of 
OA, RA or SLE. Data on specific CAM therapies used, reasons 
for use and assessment of efficacy were collected, as well as in- 
formation on health related quality of life (SF-36). 
Results: The response rate was 183/474 (38.6%) total (OA 
88/208 (42%); RA 51/140 (36%); SLE 44/126 (35%)). Overall, 
CAM was used by 65/88 (74%) with OA, 28/51 (55%) with RA 
and 27/44 (61%) with SLE. the most common therapies used by 
each group are listed in the table below. Nutraceutical use was 
substantially more common among, but not unique to, those with 
OA. SLE pts were more likely to use mind-body interventions than 
either arthritis group. Pts used CAM for pain relief: OA: 56/88 
(64%), RA: 21/51 (41%),SLE: 12/44 (27%); for relief of stiffness: 
OA: 48/88 (55%), RA: 21/51 (41%), SLE: 17/44 (39%); for "im- 
mune system problem": OA: 8/88 (10%), RA: 5/51 (10%), SLE: 
9/44 (20%). 
Most Common CAM Therapies By Diagnosis 
OA (n=88) RA (n=51) SLE (n=44) 
glucosamine 39% vitamins 37% vitamins 41% 
chondroitin 38% prayer 24% prayer 30% 
vitamins 36% diet 22% massage 20% 
massage 23% massage 22% diet 18% 
prayer 20% meditation 10% meditation 16% 
diet 14% glucosamine 10% yoga 16% 
chiropractic 11% acupuncture 10% acupuncture 14% 
acunpuncture 10% chondroitin 8% chiropractic 11% 
meditation 7% herbal medicine 8% cognitive therapy 11% 
yoga 6% therapeutic touch 8% imagery 10% 
OA pts were less likely to think CAM was helping them than those 
with RA or SLE. All groups were most likely to think the com- 
bination of CAM and prescription medicines was better than ei- 
ther alone. SF-36 revealed that OA pts scored worse in physical 
functioning and pain than others. OA pts who used CAM plus 
prescription medications had less role limitation due to emotional 
problems than OA pts who used prescribed drugs alone. OA pts 
who used CAM alone scored better in virtually all categories of 
the SF-36 than RA or SLE pts who used CAM alone; OA pts who 
used no medications scored worse in all categories. 
Conclusions: This survey confirms previous studies showing a 
high frequency of CAM use among pts with rheumatic disease, 
regardless of diagnosis. OA pts have the highest rate of use, are 
more likely to be seeking relief of pain and stiffness, and view 
themselves as having more pain and impairment of physical func- 
tioning than pts with RA or SLE. CAM use in OA was correlated 
with better emotional well-being. 
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Objective: To describe the characteristics of the French pa- 
tients with hip osteoarthritis (OA) undergoing total hip arthro- 
plasty (THA). 
Methods: A questionnaire was sent to 1600 general practition- 
ers and 400 rheumatologists. All the practitioners were asked 
to prospectively include one patient with hip OA for whom THA 
was planed to be performed within the next 3 months (population 
1) and/or one patient with hip OA for whom a visit with a sur- 
geon was planed to be performed within the next 3 months to find 
out whether THA was indicated (population 2) and/or one control 
patient with hip OA (population 3). The following variables were 
obtained: age, gender, status regarding work, body mass index 
(BMI), co-morbidities, index hip OA duration, other OA Iocalisa- 
tion, patient's global assessment of OA condition (visual numeric 
scale), WOMAC pain and function subscale scores, New Zealand 
score, quality of life (SF 12 score), patient's expectation regard- 
ing surgery. Additionally, X-rays were obtained, numerized and 
assessed by three independent readers. What follows is a pre- 
sentation and a discussion regarding the results from population 
1. 
Results: Six hundred and eighty five patients for whom THA was 
planed responded to the questionnaire, 529 of them were in- 
cluded by general practitioners and 156 by rheumatologists. The 
mean age of the 685 patients (277 males, 408 females) was 69 
years 4- 9.4, and the mean BMI was 26.3 4- 3.6 kg/m 2. Most were 
retired (82.8%). A significant cardio-vascular disease was present 
in 9.7%, and 1.6% presented with respiratory deficiency. Disease 
duration was 5.4 years 4- 4.2. Hip OA was bilateral in 46.3% of 
the patients, and 52.8% suffered from symptomatic knee OA. The 
mean patient's global assessment of OA condition, WOMAC pain 
and function, New Zealand, and SF 12 physical and mental health 
scores were 7.3 4-1.5, 62.4 4- 13.7, 65 4- 14, 59.9 4- 15.8, 27.2 4- 
5.4, and 41.6 4- 10.8, respectively. Expectations regarding arthro- 
plasty were low (1.2%), intermediate (16.6%) and high (82.2%). 
The Kelgren and Lawrence score of the index hip was 3 or 4 in 
68.6% of patients. 
Conclusion: The demographic haracteristics of French patients 
undergoing THA for hip OA are comparable to those observed 
in other developed countries. The patients frequently experience 
severe pain and are severely disabled, and most present with 
a structurally advanced disease. Major variations in the annual 
THA rates have recently been reported among developed coun- 
tries, France belonging to those with the highest rates. This study 
suggests that differences in THA rates between France and some 
other countries are not due to inter-country differences in the per- 
ception of the level of OA severity at which THA would be appro- 
priate. 
